Skip to main content
Argon pellet injection text

As scientists study approaches to best sustain a fusion reactor, a team led by Oak Ridge National Laboratory investigated injecting shattered argon pellets into a super-hot plasma, when needed, to protect the reactor’s interior wall from high-energy runaway electrons.

Oak Ridge National Laboratory scientists have developed an experiment for testing potential materials for use in interplanetary travel. The experiment exposes prototype materials to temperatures over 2,400 degrees Celsius with only 300 watts of input electrical power. Credit: Carlos Jones, Oak Ridge National Laboratory, U.S. Dept. of Energy

If humankind reaches Mars this century, an Oak Ridge National Laboratory-developed experiment testing advanced materials for spacecraft may play a key role. 

early prototype of the optical array developed by Oak Ridge National Laboratory.

IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.

Nuclear—Deep space travel

By automating the production of neptunium oxide-aluminum pellets, Oak Ridge National Laboratory scientists have eliminated a key bottleneck when producing plutonium-238 used by NASA to fuel deep space exploration.

exp_in_10_dry_tube.jpg

Scientists from Oak Ridge National Laboratory performed a corrosion test in a neutron radiation field to support the continued development of molten salt reactors.

X1800-REED-Maritime Risk Symposium 2018 logo-AM V5-01.jpg

Thought leaders from across the maritime community came together at Oak Ridge National Laboratory to explore the emerging new energy landscape for the maritime transportation system during the Ninth Annual Maritime Risk Symposium.

Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.

The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.